Disease Area

treatment resistant depression

Treatment Resistant Depression is an active area of clinical research and therapeutic development covered by The Life Science Feed. Our editorial team tracks the latest clinical trials, treatment guidelines, regulatory updates, and scientific advances relevant to Treatment Resistant Depression. Browse the latest articles below for in-depth analysis and evidence-based clinical insights.

Treatment-Resistant Depression
Esketamine vs. Quetiapine: Which Augmentation Strategy for TRD?
A head-to-head trial compared esketamine and quetiapine as augmentation strategies for treatment-resistant depression, offering insights into their relative efficacy and tolerability.
Get the full story
13 min read
Treatment-Resistant Depression
Treatment resistance: Why a shifting definition changes who gets care
The threshold for defining treatment resistance directly impacts patient eligibility for advanced therapies, creating disparities in access to care.
Get the full story
13 min read

Loading articles...